Hearing Screening Test Results of Newborns Conceived by Intracytoplasmic Sperm Injection: A Retrospective Study of Tertiary Referral Center.

Autor: Yasemin Sert U; Department of Obstetrics and Gynecology, Zekai Tahir Burak Kadin Sagligi EAH, Ankara, Turkey., Kansu Celik H; Department of Obstetrics and Gynecology, Zekai Tahir Burak Kadin Sagligi EAH, Ankara, Turkey., Canpolat FE; Department of Neonotolgy, Zekai Tahir Burak Kadin Sagligi EAH, Ankara, Turkey., Sımsek GK; Department of Neonotolgy, Zekai Tahir Burak Kadin Sagligi EAH, Ankara, Turkey., Engin Ustun Y; Department of Obstetrics and Gynecology, Zekai Tahir Burak Kadin Sagligi EAH, Ankara, Turkey.
Jazyk: angličtina
Zdroj: Fetal and pediatric pathology [Fetal Pediatr Pathol] 2020 Aug; Vol. 39 (4), pp. 288-296. Date of Electronic Publication: 2019 Aug 23.
DOI: 10.1080/15513815.2019.1651804
Abstrakt: Objective: Assisted reproductive technologies (ART), especially intracytoplasmic sperm injection (ICSI), is associated with birth defects. However, there are few reports on hearing screening tests of these babies. We aimed to determine the association between ART and hearing loss in newborns. Materials and methods: This retrospective study examined 246 ICSI newborns between 2013 and 2015. All the patients conceived by ICSI. We examined the hearing screening results of the babies. Results: A total of 25 newborns did not pass the first screening test, including 17 by transient evoked otoacoustic emission (TEOAE) and 8 by auditory brainstem response (ABR). Ten babies did not pass the advanced examination. Total hearing loss affected 4% of ART babies. Conclusion: Hearing screening tests exposed deficient results in 4% of ICSI babies, which is ten times more frequent than spontaneously conceived newborns.
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje